Your browser doesn't support javascript.
Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response"by Bonelli et al.
Benucci, Maurizio; Damiani, Arianna; Infantino, Maria; Manfredi, Mariangela; Grossi, Valentina; Lari, Barbara; Li Gobbi, Francesca; Sarzi Puttini, Piercarlo.
  • Benucci M; Rheumatology Unit, San Giovanni di Dio Hospital, Azienda USL Toscana Centro, Firenze, Italy maubenucci@tiscali.it.
  • Damiani A; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Florence, Firenze, Italy.
  • Infantino M; Immunology and Allergology Laboratory, San Giovanni di Dio Hospital, Florence, Italy.
  • Manfredi M; Immunology and Allergology Laboratory, San Giovanni di Dio Hospital, Florence, Italy.
  • Grossi V; Immunology and Allergology Laboratory, San Giovanni di Dio Hospital, Florence, Italy.
  • Lari B; Immunology and Allergology Laboratory, San Giovanni di Dio Hospital, Florence, Italy.
  • Li Gobbi F; Rheumatology Unit, San Giovanni di Dio Hospital, Firenze, Italy.
  • Sarzi Puttini P; Rheumatology Unit, ASST-Fatebenefratelli L. Sacco University Hospital, University of Milan, Milan, Italy.
Ann Rheum Dis ; 80(10): e166, 2021 10.
Article in English | MEDLINE | ID: covidwho-1338843
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Ann Rheum Dis Year: 2021 Document Type: Article Affiliation country: Annrheumdis-2021-220829

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Ann Rheum Dis Year: 2021 Document Type: Article Affiliation country: Annrheumdis-2021-220829